SCHEMBL7039773

SCHEMBL7039773

CC(C)CN(C)c1cc(N(C(=O)OC(C)(C)C)[N+](=O)[O-])ccc1C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H3 Q13133 2/20 0.33
RXRA P19793 1/20 0.33
NR1H2 P55055 1/20 0.33
MAPK1 P28482 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
GAA P10253 1/20 0.32
CACNA1G O43497 1/20 0.32
CACNA1B Q00975 1/20 0.32
CACNA1C Q13936 1/20 0.32
LMNA P02545 2/20 0.31
POLB P06746 1/20 0.31
RAB9A P51151 1/20 0.30
MLYCD O95822 1/20 0.30
CES2 O00748 1/20 0.30
ABCB11 O95342 1/20 0.30
ALDH1A1 P00352 1/20 0.30
CYP1A2 P05177 1/20 0.30
GLA P06280 1/20 0.30
CYP3A4 P08684 1/20 0.30
ADORA3 P0DMS8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6622345 0.86 AAK1 (0.31)
SCHEMBL7047741 0.81 ALDH1A1 (0.36) NR1H3RXRANR1H2CACNA1GCACNA1B
SCHEMBL6607932 0.80 LMNA (0.35) NR1H3RXRANR1H2MAPK1SMN1; SMN2
SCHEMBL17336687 0.79 LMNA (0.36) NR1H3RXRANR1H2MAPK1SMN1; SMN2
SCHEMBL6872851 0.78 RXRA (0.36) NR1H3RXRANR1H2MAPK1SMN1; SMN2
SCHEMBL17336893 0.78 NOTUM (0.36) NR1H3RXRANR1H2CACNA1GCACNA1B
SCHEMBL7113987 0.77 RXRA (0.35) NR1H3RXRANR1H2LMNAPOLB
SCHEMBL7045105 0.75 LMNA (0.33) NR1H3RXRANR1H2CACNA1GCACNA1B
SCHEMBL5558208 0.73 RBP4 (0.36)
SCHEMBL7111182 0.72 IDO1 (0.35) MAPK1SMN1; SMN2GAALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1474416-A1 DIHYDROBENZODIAZEPIN-2-ONE-DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2004-11-10 EP disclosed
WO-2003066623-A1 DIHYDROBENZODIAZEPIN-2-ONE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 WO disclosed